| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021137489 |
| P356 | DOI | 10.2165/11631550-000000000-00000 |
| P698 | PubMed publication ID | 22559274 |
| P2093 | author name string | Paul M Arnstein | |
| P2860 | cites work | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 |
| Topical rubefacients for acute and chronic pain in adults | Q24241792 | ||
| Acetaminophen for osteoarthritis | Q24244676 | ||
| Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain | Q24564501 | ||
| Opioid analgesics and the risk of fractures in older adults with arthritis | Q24607425 | ||
| EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 | ||
| Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review | Q27692078 | ||
| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
| Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks | Q28200571 | ||
| Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden | Q28209970 | ||
| The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults | Q28212030 | ||
| Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
| Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk | Q28219220 | ||
| Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management | Q28221052 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II | Q28396036 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials | Q33205361 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines | Q33320085 | ||
| Oral versus topical NSAIDs in rheumatic diseases: a comparison | Q34059371 | ||
| Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression | Q34088079 | ||
| Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation --- United States, 2007-2009. | Q34142378 | ||
| Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity | Q34153131 | ||
| American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee | Q34273218 | ||
| Liver function and phase I drug metabolism in the elderly: a paradox | Q34481252 | ||
| The comparative safety of opioids for nonmalignant pain in older adults | Q34625722 | ||
| Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy | Q34995630 | ||
| Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis | Q35122667 | ||
| Primary osteoarthritis of hip, knee, and hand in relation to occupational exposure | Q35502104 | ||
| Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. | Q36591918 | ||
| Age-related changes in pharmacokinetics: predictability and assessment methods | Q36791591 | ||
| Modulation of immune function by morphine: implications for susceptibility to infection | Q37015395 | ||
| Sports cream and arthritic rubs: the hidden dangers of unrecognized salicylate toxicity | Q37036864 | ||
| Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors | Q37385351 | ||
| An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs | Q37465540 | ||
| Balancing analgesic efficacy with safety concerns in the older patient | Q37761525 | ||
| Targeted treatment of pruritus: a look into the future | Q37827172 | ||
| Topical preparations for pain relief: efficacy and patient adherence | Q37851017 | ||
| What of guidelines for osteoarthritis? | Q37868774 | ||
| Topical therapies for osteoarthritis | Q37902642 | ||
| Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. | Q39358260 | ||
| Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. | Q39375264 | ||
| Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response | Q39683632 | ||
| More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib | Q40361729 | ||
| Gait variability and fall risk in community-living older adults: a 1-year prospective study | Q40692815 | ||
| Oral versus topical Ibuprofen for chronic knee pain: a prospective randomized pilot study | Q42880407 | ||
| Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. | Q43175838 | ||
| Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. | Q44782762 | ||
| A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. | Q44941344 | ||
| Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis | Q46043948 | ||
| Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis | Q46068912 | ||
| Quality of life among older adults with osteoarthritis: an explorative study. | Q50928132 | ||
| Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. | Q51924187 | ||
| Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. | Q51990035 | ||
| Prevalence and burden of osteoarthritis: results from a population survey in Norway. | Q53158014 | ||
| Nonsteroidal antiinflammatory drug gastropathy: we started it, why don't we stop it? | Q53291067 | ||
| The cost and frequency of hospitalization for fall-related injuries in older adults | Q68163614 | ||
| An update on the epidemiology of knee and hip osteoarthritis with a view to prevention | Q77093064 | ||
| Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs | Q77909965 | ||
| When bad evidence happens to good treatments | Q81144558 | ||
| Medication use as a risk factor for falls among hospitalized elderly patients | Q81517031 | ||
| Drug metabolism and ageing | Q81876189 | ||
| Pharmacological management of persistent pain in older persons | Q84159023 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| P304 | page(s) | 523-531 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Evolution of topical NSAIDs in the guidelines for treatment of osteoarthritis in elderly patients | |
| P478 | volume | 29 |
| Q47101605 | A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients. |
| Q38437249 | Comparative bioavailability and tolerability of single and multiple doses of 2 diclofenac sodium sustained-release tablet formulations in fasting, healthy chinese male volunteers |
| Q48534200 | Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific |
| Q40433583 | Injectable Polysaccharide Hydrogels as Biocompatible Platforms for Localized and Sustained Delivery of Antibiotics for Preventing Local Infections |
| Q39219199 | Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study |
| Q59137615 | Managing Chronic Pain in the Elderly: An Overview of the Recent Therapeutic Advancements |
| Q38239116 | Narcotics in rheumatology |
| Q38551448 | Topical treatment in pain medicine: from ancient remedies to modern usage |
Search more.